Free Trial

Barclays PLC Has $2.19 Million Holdings in AMERISAFE, Inc. (NASDAQ:AMSF)

AMERISAFE logo with Finance background

Barclays PLC boosted its holdings in shares of AMERISAFE, Inc. (NASDAQ:AMSF - Free Report) by 27.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 42,430 shares of the insurance provider's stock after acquiring an additional 9,211 shares during the quarter. Barclays PLC owned 0.22% of AMERISAFE worth $2,188,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of the stock. Virtu Financial LLC purchased a new stake in shares of AMERISAFE during the 3rd quarter worth $200,000. JPMorgan Chase & Co. increased its stake in AMERISAFE by 17.5% in the 3rd quarter. JPMorgan Chase & Co. now owns 34,726 shares of the insurance provider's stock worth $1,678,000 after purchasing an additional 5,168 shares in the last quarter. GAMMA Investing LLC lifted its holdings in shares of AMERISAFE by 63.4% during the 4th quarter. GAMMA Investing LLC now owns 1,343 shares of the insurance provider's stock valued at $69,000 after buying an additional 521 shares during the last quarter. Nisa Investment Advisors LLC increased its position in AMERISAFE by 1,328.5% in the 4th quarter. Nisa Investment Advisors LLC now owns 5,914 shares of the insurance provider's stock worth $305,000 after buying an additional 5,500 shares during the period. Finally, Exchange Traded Concepts LLC lifted its holdings in shares of AMERISAFE by 4.3% during the fourth quarter. Exchange Traded Concepts LLC now owns 36,434 shares of the insurance provider's stock valued at $1,878,000 after acquiring an additional 1,494 shares during the period. Hedge funds and other institutional investors own 97.41% of the company's stock.

AMERISAFE Stock Up 1.8 %

NASDAQ:AMSF traded up $0.81 on Friday, hitting $46.64. The stock had a trading volume of 94,069 shares, compared to its average volume of 109,892. The stock has a market cap of $888.49 million, a price-to-earnings ratio of 14.58 and a beta of 0.41. The business's 50-day simple moving average is $50.24 and its two-hundred day simple moving average is $52.15. AMERISAFE, Inc. has a 52-week low of $41.97 and a 52-week high of $60.24.

AMERISAFE (NASDAQ:AMSF - Get Free Report) last issued its quarterly earnings results on Tuesday, April 29th. The insurance provider reported $0.60 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.59 by $0.01. The company had revenue of $83.78 million for the quarter, compared to the consensus estimate of $76.66 million. AMERISAFE had a return on equity of 16.50% and a net margin of 19.49%. As a group, equities research analysts anticipate that AMERISAFE, Inc. will post 2.45 EPS for the current year.

AMERISAFE Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 20th. Stockholders of record on Friday, June 13th will be issued a dividend of $0.39 per share. The ex-dividend date of this dividend is Friday, June 13th. This represents a $1.56 dividend on an annualized basis and a dividend yield of 3.34%. AMERISAFE's payout ratio is 62.90%.

Analyst Ratings Changes

Separately, JMP Securities reiterated a "market outperform" rating and set a $65.00 target price on shares of AMERISAFE in a research note on Wednesday.

Get Our Latest Stock Report on AMERISAFE

About AMERISAFE

(Free Report)

AMERISAFE, Inc, an insurance holding company, underwrites workers' compensation insurance in the United States. The company provides benefits to injured employees for temporary or permanent disability, death, and medical and hospital expenses. It sells its products through retail and wholesale brokers and agents; and small and mid-sized employers engaged in hazardous industries, including construction, trucking, logging and lumber, agriculture, manufacturing, telecommunications, and maritime.

Read More

Institutional Ownership by Quarter for AMERISAFE (NASDAQ:AMSF)

Should You Invest $1,000 in AMERISAFE Right Now?

Before you consider AMERISAFE, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMERISAFE wasn't on the list.

While AMERISAFE currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy Early: 3 Tech Trends With Millionaire-Making Potential
5 Stocks to BUY NOW in May 2025
3 Stocks Offering Rare Generational Buying Opportunities

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines